Specific red cell adherence test applied to tumors of ureter and renal pelvis.
The specific red cell adherence (SRCA) test used previously as a prognostic indicator of bladder tumors was used in a retrospective review of 14 patients with transitional cell carcinoma of the ureter and renal pelvis. SRCA-positive individuals appear to have better survival and progress less frequently to metastatic disease. Of five patients with positive reactions, none had distant metastases. Conversely, in SRCA-negative individuals metastatic disease developed more frequently (4 of 9). The SRCA test can be as useful a test of the prognosis of ureteral and renal pelvis tumors as it is of urinary bladder tumors.
D000328:Adult; D000368:Aged; D002295:Carcinoma, Transitional Cell / Q000276:immunology*; D004912:Erythrocytes / Q000276:immunology*; D005260:Female; D006801:Humans; D007104:Immune Adherence Reaction; D007680:Kidney Neoplasms / Q000276:immunology*; D007682:Kidney Pelvis; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D014516:Ureteral Neoplasms / Q000276:immunology*; D001749:Urinary Bladder Neoplasms / Q000276:immunology